Ipratropium Bromide/Salbutamol Neutec

Ipratropium bromide, the active ingredient in Ipratropium Bromide/Salbutamol Neutec, is a combination bronchodilator presented as an inhalation formulation for inhalation use. It treats asthma and chronic obstructive pulmonary disease (COPD) in adults.\nGNH India supplies Ipratropium Bromide/Salbutamol Neutec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipratropium bromide and salbutamol act on the airways to provide bronchodilation for obstructive lung diseases.\n\nAsthma: rapid relief of bronchoconstriction and improvement of airflow.\nCOPD: enhances bronchodilation to reduce symptoms and exacerbations.\nAcute bronchospasm: provides prompt bronchodilation during sudden airway narrowing.

The following adverse reactions have been reported with the combination inhaler.\n\nCommon Side Effects:\n- Dry mouth\n- Cough or throat irritation\n- Tremor\n- Headache\n\nSerious or Rare Side Effects:\n- Paradoxical bronchospasm\n- Angioedema or severe hypersensitivity\n- Tachycardia or arrhythmia\n- Significant hypertension

Before prescribing, clinicians should consider several safety aspects.\n\nAssess cardiac status: monitor for tachyarrhythmias in patients with heart disease.\nMonitor for paradoxical bronchospasm: discontinue if severe wheezing occurs.\nUse with caution in narrow‑angle glaucoma: anticholinergic effect may increase intra‑ocular pressure.\nAvoid in patients with known hypersensitivity to either component.\nStore at room temperature: keep in original container, protect from moisture and direct sunlight.

Ipratropium bromide/salbutamol may interact with other medications affecting the cardiovascular or respiratory systems.\n\nMajor Interactions (Avoid):\n- Non‑selective β‑blockers: may diminish bronchodilator effect.\n- MAO inhibitors or tricyclic antidepressants: increase risk of cardiovascular side effects.\n- Diuretics: may exacerbate hypokalemia when combined with β2‑agonists.\n\nModerate Interactions (Monitor Closely):\n- Theophylline: additive bronchodilator effect may increase toxicity.\n- Other inhaled bronchodilators: monitor for cumulative cardiovascular stimulation.